Clinical Report: Worldwide Patterns and Scholarly Insights on AI in BCC Research
Overview
This bibliometric study reveals a significant increase in publications on artificial intelligence (AI) in basal cell carcinoma (BCC) research, particularly post-2019. The United States and China lead in contributions, with a focus on deep learning applications in dermoscopic image analysis.
Background
Basal cell carcinoma (BCC) is the most common skin cancer, necessitating timely diagnosis to prevent local tissue damage and improve patient outcomes. The integration of artificial intelligence (AI) in dermatology offers potential advancements in early detection and management of BCC. However, comprehensive analyses of AI's role in BCC research have been limited, highlighting the need for systematic exploration of this emerging field.
Data Highlights
{'format': 'Ensure the table is properly formatted in the final document.'}
Key Findings
{'add_data': 'Include specific data points or references to support claims.'}
Clinical Implications
The rapid growth of AI research in BCC underscores the importance of integrating these technologies into clinical practice for improved diagnostic accuracy. Clinicians should stay informed about AI advancements to enhance early detection and management strategies for BCC.
Conclusion
AI research in BCC is expanding rapidly, indicating a promising future for its application in clinical settings. Continued exploration and validation of AI systems are essential for their effective integration into routine practice.
